Metastatic melanoma in a 95 years old patient responding to treatment with talimogene laherparepvec followed by nivolumab

被引：3
|
作者：
Naqash, Abdul R. [1 ]
Stroud, Geoffrey [1 ]
Collichio, Frances A. [2 ]
Muzaffar, Mahvish [1 ]
Sharma, Nitika [1 ]
Walker, Paul [1 ]
机构：
[1] East Carolina Univ, Div Hematol Oncol, 600 Moye Blvd, Greenville, NC 27858 USA
[2] Univ N Carolina, Div Hematol Oncol, Lineberger Comprehens Ctr, Chapel Hill, NC USA
来源：
ACTA ONCOLOGICA | 2017年 / 56卷 / 10期
关键词：
IPILIMUMAB; IMMUNOTHERAPY; COMBINATION;
D O I：
10.1080/0284186X.2017.1324212
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1327 / 1330
页数：4
相关论文
共 50 条
  • [21] Talimogene laherparepvec (T-VEC) as a treatment for melanoma: A systematic review
    Alla, Sai Santhosha Mrudula
    Tekuru, Yogesh
    Lokesh, Moraboina Sai
    Alla, Deekshitha
    Tvisha, Patel
    Tirupati, Soujanya
    Singh, Aradhya
    Tejaswini, Yeshala
    Mahmood, Mariya
    Siingh, Nanki Pratap
    Vineetha, Bodipudi
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2025,
  • [22] Spotlight on talimogene laherparepvec for the treatment of melanoma lesions in the skin and lymph nodes
    Orloff, Marlana
    ONCOLYTIC VIROTHERAPY, 2016, 5 : 91 - 98
  • [23] Pharmacokinetic drug evaluation of talimogene laherparepvec for the treatment o advanced melanoma
    Burke, Erin E.
    Zager, Jonathan S.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (04) : 469 - 473
  • [24] Combined Regional Approach of Talimogene laherparepvec and Radiotherapy in the Treatment of Advanced Melanoma
    Tam, Andrew
    Ladbury, Colton
    Kassardjian, Ari
    Modi, Badri
    McGee, Heather
    Melstrom, Laleh
    Margolin, Kim
    Xing, Yan
    Amini, Arya
    CANCERS, 2024, 16 (11)
  • [25] Imaging Manifestations of Pseudoprogression in Metastatic Melanoma Nodes Injected with Talimogene Laherparepvec: Initial Experience
    Zamora, C.
    Lopez, M.
    Cunningham, F.
    Collichio, F.
    Castillo, M.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2017, 38 (06) : 1218 - 1222
  • [26] Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanoma
    Chesney, Jason
    Puzanov, Igor
    Collichio, Frances
    Milhem, Mohammed M.
    Hauschild, Axel
    Chen, Lisa
    Sharma, Anjali
    Garbe, Claus
    Singh, Parminder
    Mehnert, Janice M.
    BRITISH JOURNAL OF CANCER, 2019, 121 (05) : 417 - 420
  • [27] Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanoma
    Jason Chesney
    Igor Puzanov
    Frances Collichio
    Mohammed M. Milhem
    Axel Hauschild
    Lisa Chen
    Anjali Sharma
    Claus Garbe
    Parminder Singh
    Janice M. Mehnert
    British Journal of Cancer, 2019, 121 : 417 - 420
  • [28] Safety of Talimogene Laherparepvec in the Geriatric Melanoma Patient: A Multi-Institutional Experience
    Johnson, J.
    Louie, R. J.
    Carr, M. J.
    Baecher, K.
    Collichio, F.
    Lowe, M. C.
    Sarnaik, A. A.
    Delman, K. A.
    Zager, J. S.
    Ollila, D. W.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S107 - S108
  • [29] Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review
    Kalsi, Simran
    Galenkamp, Amanda L.
    Singh, Rohit
    Khosla, Atulya Aman
    Mcgranaghan, Peter
    Cintolo-Gonzalez, Jessica
    CURRENT ONCOLOGY REPORTS, 2024, 26 (12) : 1651 - 1663
  • [30] Treatment of melanoma using talimogene laherparepvec and vemurafenib combination therapy in murine model
    Fu, Y.
    de Moll, E. H.
    Beers, C.
    Bhardwaj, N.
    Lebwohl, M. G.
    Saenger, Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S39 - S39
12345